Sponsor:
University Health Network, Toronto
Code:
NCT02186574
Conditions
Hepatitis B
Lymphoma
Non-Hodgkin
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tenofovir disoproxil
Placebo Oral Tablet
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-23. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2019-12-12.